Deschatelets Pascal (CIK 1657720) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (1.2M shares), Buy APLS (41,250 shares), Sell APLS (41,250 shares), Buy APLS (10,030 shares), Sell APLS (10,030 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 1.2M | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Buy | 41,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 41,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Buy | 10,030 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 10,030 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Buy | 12,920 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 12,920 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Buy | 25,840 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 25,840 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 4,909 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 3,372 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 11,284 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 25,840 | $0 |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Buy | 25,840 | $0 |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 5,928 | $129,053 |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 909 | $17,989 |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Sell | 2,277 | $50,527 |
| 2025-05-22 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Scientific Officer | Buy | 12,780 | $48,053 |
Source: SEC Form 4 filings · as of 2026-05-14